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Cellular aging is accompanied by alterations in gene expression patterns. Here, using two models of repli-
cative senescence, we describe the inﬂuence of the RNA-binding protein HuR in regulating the expression of
several genes whose expression decreases during senescence. We demonstrate that HuR levels, HuR binding to
target mRNAs encoding proliferative genes, and the half-lives of such mRNAs are lower in senescent cells.
Importantly, overexpression of HuR in senescent cells restored a “younger” phenotype, while a reduction in
HuR expression accentuated the senescent phenotype. Our studies highlight a critical role for HuR during the
process of replicative senescence.
Human diploid ﬁbroblasts exhibit a ﬁnite life span in culture.
Following a limited number of cell divisions, they exit the cell
cycle and may remain viable for long periods in a state known
as replicative senescence (3). As this process is thought to re-
ﬂect aspects of organismal aging, human primary cells have
been used extensively to study cellular proliferation, immortal-
ity, and growth arrest. Over the years, and employing a variety
of model systems, investigators have reported collections of genes
whose expression levels are altered in senescent cells relative
to young cells. Examples of genes whose expression is elevat-
ed in senescent cells are those for p16
INK4, p21
CIP1, cyclins
D1 and E, APP, endothelin-1, ﬁbronectin, interleukin-1, Cu,
ZnSOD, GADD45, PAI-1, PAI-2, SPARC, IGFBP-3, collage-
nase, macrophage colony-stimulating factor, p53, bcl-2, and
p33
ING1. Examples of genes whose expression is reduced in
senescent cells are those for cyclin A, cyclin B1, cyclin H, CAK,
cdc2, MnSOD, c-fos, catalase, EPC-1, E2F-1, E2F-2, DP-1,
elastin, thymidine kinase, IGF-II, egr-1, granulocyte-macro-
phage colony-stimulating factor, dihydrofolate reductase,
PCNA, ribonucleotide reductase, and histones (2, 16, 21, 22,
26, 31, 33; for reviews, see references 4, 5, 14, 32, and 37).
Many investigators have postulated the existence of common
regulatory mechanisms to account for such senescence-related
alterations in gene expression. While a number of transcrip-
tional regulators contributing to age-dependent gene expres-
sion have been identiﬁed, their inﬂuences on the senescent
phenotype are not fully understood (8, 15, 20, 24). Based on
the increasingly recognized participation of posttranscriptional
regulatory mechanisms and the observation that many senes-
cence-associated genes bear AU-rich elements, which are known
targets of regulated mRNA turnover, in their 39 untranslated
regions (UTRs), we hypothesized that their orchestrated ex-
pression may be regulated, at least in part, through coordinate
alterations in mRNA stability. Alterations in mRNA stability
require the association of the mRNAs with RNA-binding pro-
teins that either enhance or reduce their stabilities. Many RNA-
binding proteins have been described, but only a few them,
including the Elav (embryonic lethal abnormal visual)/Hu and
AUF1 protein family, have been reported to affect mRNA
half-life. The Elav/Hu family of RNA-binding proteins, includ-
ing the ubiquitously expressed HuR and the neuronal-speciﬁc
Hel-N1, HuC, and HuD, have been found to bind to critical
mRNAs containing AU-rich elements (e.g., GLUT-1, c-myc,
GAP-43, c-fos, PAI-2, VEGF, and p21 [10, 11, 25, 34, 35]) and
either stabilize them, enhance their translation, or both (10, 11,
25). By contrast, AUF1 has generally been associated with en-
hanced mRNA turnover (6, 19).
We previously described the stress-triggered stabilization of
the mRNA encoding the cyclin-dependent kinase (cdk) inhib-
itor p21 through complexing with the mRNA-binding protein
HuR and subsequently reported that mRNAs encoding cyclins
A and B1 are targeted and stabilized by HuR in a cell cycle-
regulated fashion (34, 35). Here, we employ two established
model systems of cellular senescence: in vitro passage of WI-38
human diploid ﬁbroblasts (13) and the IDH4 human ﬁbroblast
model developed by Shay and colleagues, where the normal
limitation of life span can be reversibly bypassed through in-
ducible expression of the simian virus 40 (SV40) large T anti-
gen (38). We report that senescent cells in both models had
lower HuR levels; exhibited decreased binding to transcripts of
c-fos, cyclin A, and cyclin B1; and displayed reduced stability
and steady-state levels of the respective mRNAs, suggesting
that reduced HuR binding to these mRNAs contributes to
their lower expression with aging. Strikingly, transient overex-
pression of HuR in IDH4 cells restored a “younger” pheno-
type, while antisense-RNA-mediated reduction in HuR levels
led to a more pronounced “old” phenotype. Our ﬁndings pro-
vide evidence that HuR serves to regulate the turnover of
genes whose expression is coordinately downregulated during
replicative senescence. Thus, a reduction in HuR during rep-
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notype.
MATERIALS AND METHODS
Cell culture, cell transfections, and assessment of
3H-thymidine incorpora-
tion, ﬂuorescence-activated cell sorter (FACS) distribution, and senescence-
associated b-galactosidase (SA-b-gal) activity. Human diploid IDH4 ﬁbroblasts
(generously provided by J. W. Shay) and early-passage ('28 population dou-
blings [pdl]) and late-passage ('60 pdl) human diploid WI-38 ﬁbroblasts were
cultured in Dulbecco’s modiﬁed essential medium (Gibco-BRL, Gaithersburg,
Md.) supplemented with 10% fetal bovine serum. Skin biopsy-derived human
diploid ﬁbroblasts were obtained from the CORIELL Cell Repositories (Cam-
den, N.J.). The samples included ﬁbroblasts from nine young individual donors
(15 to 30 years old) and from nine elderly individual donors (80 to 94 years old).
The cells were cultured in Dulbecco’s modiﬁed essential medium plus 10% fetal
bovine serum for approximately 3 to 4 pdl to obtain enough material for Western
blot analysis. IDH4 cell culture medium was further supplemented with 1 mM
dexamethasone (dex) for constitutive expression of SV40 large T antigen to
suppress senescence and induce proliferation (38). To induce senescence of
IDH4 cells, dex was removed from the culture media (and regular serum was
replaced with charcoal-stripped serum), and the cells were assessed at different
times (3 to 8 days) thereafter. Constructs pZeoSV2(2)HuR(S) and pZeoSV2
(2)ASHuR (antisense) were previously described (17). All transfections were
transient and were carried out using lipofectamine (Gibco-BRL), following the
manufacturer’s recommendations. This procedure resulted in a transfection ef-
ﬁciency of 75 to 90% based on parallel transfections using a green ﬂuorescent
protein-expressing plasmid.
For assessment of SA-b-gal activity, cells were seeded in 30-mm-diameter
dishes, cultured in medium without dex for different lengths of time, and then
ﬁxed with a 3% formaldehyde solution. The cells were then washed and incu-
bated with SA-b-gal staining solution (1 mg of X-Gal [5-bromo-4-chloro-3-
indolyl-b-D-galactopyranoside]/ml, 40 mM citric acid–sodium phosphate buffer
[pH 6.0], 5 mM ferrocyanide, 5 mM ferricyanide, 150 mM NaCl, and 2 mM MgCl2)
from 4 h to overnight to visualize SA-b-gal activity (7).
3H-thymidine incorpo-
ration assays and FACS analysis were performed as described previously (35).
Northern and Western blot analysis. Northern blot analysis was carried out as
previously described (12). Oligomers complementary to human cyclin D1, p21,
and 18S rRNA (18) were 39-end labeled using terminal transferase enzyme, while
PCR-generated fragments of cyclin A, cyclin B1, DP-1, gadd153, c-fos, and
b-actin cDNAs were random-primer labeled using Klenow enzyme; all labeling
reactions were carried out in the presence of [a-
32P]dATP. Signals on Northern
blots were visualized and quantitated with a PhosphorImager (Molecular Dy-
namics, Sunnyvale, Calif.).
For Western blot analysis, 40 mg of cell lysate was resolved on sodium dodecyl
sulfate-polyacrylamide gels and transferred onto polyvinylidene diﬂuoride mem-
branes. HuR was detected with the monoclonal anti-HuR antibody 19F12 (34);
anti-AUF1 (39) and anti-BAF57c (36) antibodies were previously described.
Monoclonal anti-b-actin antibody was from Santa Cruz Biotechnologies (Santa
Cruz, Calif.). Signals were detected with the ECL reagent (Amersham) and
quantitated using a Personal Densitometer (Molecular Dynamics).
Preparation of cell fractions and radiolabeled transcripts. Lysis of cells and
preparation of whole-cell lysates as well as cytoplasmic and nuclear fractions
were carried out as described previously (34). For in vitro synthesis of all tran-
scripts (either unlabeled or radiolabeled), RNA from IDH4 cells was reverse
transcribed, and the cDNAs generated were used as templates in PCRs to
amplify the 39 UTRs of cyclin A, cyclin B1, cyclin E, and c-fos cDNAs, as
described previously (34, 35). All 59 primers contained the T7 RNA polymerase
promoter sequence (T7): CCAAGCTTCTAATACGACTCACTATAGGGA
GA. Oligonucleotides used to amplify the 39 UTRs of cyclins A, B1, and E were
described previously (35); oligonucleotides (T7)GCAATGAGCCTTCCTCT
GAC and CATTCAACTTAAATGCTTTTATTG were used to prepare the c-
fos 39 UTR (region 1246 to 2101).
Binding assays. Electrophoretic mobility shift assays to detect the formation of
complexes between cellular proteins (10 mg of either cytoplasmic or nuclear
fractions) and various radiolabeled transcripts (100,000 cpm of each RNA) were
performed as described previously (34). For competition assays, 53,1 0 3,o r2 0 3
excess unlabeled transcript was used. For supershift analysis, 10 mg of cytoplas-
mic protein was incubated with 2 mg each of anti-HuR antibodies or control
antibodies recognizing p27, p38, and p53 (34).
cdk2 and cdc2 immunoprecipitation and kinase assays. Immunoprecipitation-
kinase assays were carried out as previously described (12). cdk2 and cdc2 were
immunoprecipitated from 200-mg aliquots of lysate using either anti-cdk2
(Pharmingen) or anti-cyclin B1 (Santa Cruz) antibodies, respectively. Kinase
activities were assayed using histone H1 (Ambion, Austin, Tex.) as a substrate
and quantitated with a PhosphorImager.
RESULTS
mRNAs encoding senescence-associated genes exhibit dif-
ferent relative half-lives in young and senescent cells. With
rapidly accumulating experimental evidence that altered
mRNA turnover regulates important cellular processes, we set
out to investigate whether replicative senescence is also inﬂu-
enced by altered mRNA degradation by using two established
models. The ﬁrst consisted of standard in vitro passage of
untransformed WI-38 human diploid ﬁbroblasts (13). The sec-
ond was the IDH4 human ﬁbroblast model of reversible se-
nescence developed by Wright and colleagues (38). In this
model, constitutive dex-driven SV40 large-T-antigen expres-
sion allows IDH4 cells to suppress senescence and continue to
proliferate as young cells. However, they can be induced to
quickly undergo replicative senescence by removing dex from
the culture medium, resulting in the loss of large-T-antigen
expression (38). In each cell model, comparison of young cells
(dex-treated IDH4 cells and WI-38 cells at '28 pdl) with
senescent cells (IDH4 cells cultured without dex for 3 to 7 days
and WI-38 cells at '60 pdl) revealed that senescent cells had
considerably lower cdk activity, diminished rates of
3H-thymi-
dine incorporation, and a reduced number of S- and G2-phase
cells. Likewise, a neutral SA-b-gal activity that is largely absent
from young cells (7) was greatly elevated in the senescent
cultures (Fig. 1). SA-b-gal activity is used as a biomarker for
FIG. 1. Phenotypic characterization of IDH4 cells cultured in the
presence or absence of dex. IDH4 cells that were cultured in the
presence (Young) or absence (Sen.) of dex for 7 days were subjected
to FACS analysis,
3H-thymidine incorporation assays, and assessment
of cdk2- and cdc2-associated kinase activity using histone H1 as a
substrate (A) and to SA-b-gal staining (B) (left, representative ﬁelds;
right, quantitation of SA-b-gal-positive IDH4 cells). The graphs rep-
resent the means 1 standard errors of the means of four independent
experiments.
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volved remains poorly characterized. When the expression of
senescence-regulated genes was studied (Fig. 2A), we ob-
served that the cyclin D1 mRNA levels were moderately
elevated in senescent cells, while mRNAs encoding the cdk
inhibitors p16 (not shown) and p21 were much higher in se-
nescent cells, in accordance with previous ﬁndings (9, 23, 27).
Also in agreement with previous reports, levels of mRNAs
encoding cyclin A, cyclin B1, and c-fos were greatly reduced in
both senescent WI-38 ('60 pdl) and IDH4 cells (7 days after
dex was removed) (28, 30).
In order to determine if these age-related differences in gene
expression were inﬂuenced by changes in the stabilities of the
respective mRNAs, we examined mRNA half-life in young and
senescent populations after addition of actinomycin D. As
shown in Fig. 2B, proliferating (with dex) and senescent (with-
out dex) IDH4 cells showed marked differences in the half-
lives of mRNAs encoding cyclin A, cyclin B1, and c-fos. For
these three mRNAs, treatment with actinomycin D resulted in
faster transcript loss in the populations without dex, revealing
that their stabilities were lower in senescent cells. These dif-
ferences in mRNA stability were speciﬁc for a subset of genes,
since the stabilities of other genes studied were unchanged.
p21 mRNA stability did not seem to differ between proliferat-
ing and senescent populations, despite elevated p21 expression
with senescence. Similarly, the gadd153 and b-actin mRNAs
showed no differences in stability as a function of cell senes-
cence. Basal gadd153 was unchanged between proliferating
and senescent IDH4 cells, while basal b-actin mRNA levels
were moderately reduced in senescent cultures (Fig. 2B).
When the mRNA half-lives were calculated, they were found
to be 4 h (in proliferating cells) versus 2 h (in senescent cells)
for cyclin A, 4.3 versus 2 h for cyclin B1, and 1.2 versus 0.5 h
for c-fos (Fig. 2B, graph). By contrast, the b-actin mRNA
half-lives were essentially the same in proliferating and senes-
cent IDH4 cells (about 13 to 14 h). A similar assessment of
mRNA half-life in early-passage and senescent WI-38 cells
revealed comparable differences, with young populations ex-
hibiting longer half-lives of mRNAs encoding cyclin A, cyclin
B1, and c-fos than did senescent cells (not shown).
HuR levels are lower in ﬁbroblasts undergoing replicative
senescence and in skin biopsy ﬁbroblasts from elderly indi-
viduals. Since mRNAs encoding c-fos, cyclin A, and cyclin B1
have been reported to be targets of the RNA-binding protein
HuR, and their half-lives are known to increase upon HuR
binding, we investigated whether HuR levels change with se-
nescence. As shown in Fig. 3A, HuR expression was found to
be high in young cells but decreased signiﬁcantly with replica-
tive senescence in both WI-38 and IDH4 cells. This decrease
affected total cellular HuR, with more pronounced reductions
in cytoplasmic HuR than in nuclear HuR. It was important to
assess the levels of cytoplasmic HuR because our earlier stud-
ies suggested that critical binding of HuR to target mRNAs
leading to their altered half-lives occurred in the cytoplasm
(34, 35). The quality of the subcellular fractionation, as well as
differences in loading and transfer among samples, was mon-
itored by hybridization with antibodies recognizing b-actin (a
cytoplasmic protein) and BAF57c (a nuclear protein). As de-
picted in Fig. 3B, reductions in HuR levels occurred gradually
as cells progressed towards senescence.
We extended our analysis of HuR expression to skin ﬁbro-
blasts obtained from individual donors of different ages. As
shown in Fig. 4, HuR expression in ﬁbroblasts derived from
young individuals (15 to 30 years of age) was, on average, about
2.5-fold higher than that seen in ﬁbroblasts from elderly donors
(80 to 94 years of age). Although the growth of these ﬁbroblast
cultures was not formally measured, there was a good corre-
lation between the rate of cell growth and HuR expression
levels: fast-growing cultures (those derived from young donors
and several of those derived from elderly donors) exhibited
high levels of HuR expression, with slow-growing cultures (de-
rived from elderly donors) showing reduced HuR expression.
While this system has important limitations (such as the small
sample sizes available for experimentation), it provides evi-
dence suggesting that HuR expression may also be altered
during in vivo aging.
HuR binding to target mRNAs decreases with senescence.
Lysates prepared from either young or senescent cells exhib-
ited abundant binding to radiolabeled RNAs comprising the
39 UTRs of the cyclin A, cyclin B1, and c-fos transcripts (Fig.
5). As shown, for each transcript tested, nuclear lysates pre-
FIG. 2. Senescence-associated gene expression in WI-38 and IDH4
ﬁbroblasts. (A) Northern blot analysis of expression of the genes in-
dicated using early-passage (Young; '28 pdl) and late-passage (senes-
cent [Sen.]; '60 pdl) WI-38 cells, as well as young (dex-treated) and
senescent (7 days after removing dex) IDH4 cells. (B) Stabilities of
cyclin A, cyclin B1, c-fos, and b-actin mRNAs in IDH4 cells that were
either dex-treated [Young (1dex)] or cultured without dex for 7 days
[Senescent (2dex)] were assessed after the addition of 2 mg of acti-
nomycin D/ml; preparation of RNA at the times indicated; measure-
ment of cyclin A, cyclin B1, c-fos, and b-actin mRNA Northern blot
signals; normalizing them to 18S rRNA; and plotting them on a log-
arithmic scale (bottom). Dashed horizontal lines, 50% of untreated.
The data represent the means 6 standard errors of the means of four
independent experiments.
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binding pattern and intensity as did lysates prepared from
senescent cells (Fig. 5). Similar results were observed when
WI-38 cells were used (not shown). Remarkably, however,
proteins present in cytoplasmic lysates prepared from young
cells (both proliferating IDH4 and early-passage WI-38 cells)
revealed much more extensive binding to radiolabeled tran-
scripts than did proteins present in cytoplasmic lysates from
senescent cells. That HuR was part of these senescence-sensi-
tive complexes was evidenced by the ability of an anti-HuR
antibody to supershift some of the protein-RNA associations,
while antibodies directed to unrelated proteins did not pro-
duce supershifts (Fig. 5). These age-dependent associations
with HuR were speciﬁc for cyclin A, cyclin B1, and c-fos, since
assessment of a control radiolabeled RNA (encoding the cyclin
E3 9 UTR) in binding assays revealed no differences associated
with cell senescence and similarly failed to produce supershifts
(Fig. 5). Other control transcripts (those encompassing the
coding region and 59 UTRs of the three genes) likewise failed
to show this age-dependent difference in complex formation,
and no supershifts were observed (not shown).
These age-dependent binding activities were further charac-
terized, as shown in Fig. 6. Decreasing complex formation was
seen in lysates from cells that were advancing towards senes-
cence (Fig. 6A). Binding speciﬁcity was assessed using com-
peting unlabeled transcripts. Complex formation was inhibited
when lysates were preincubated with 5-, 10-, or 20-fold excess
speciﬁc, or “self,” unlabeled transcript (that is, unlabeled cyclin
A transcript in the case of shifts using radiolabeled cyclin A,
FIG. 3. HuR expression in young and senescent human ﬁbroblasts.
(A) Western blot analysis of HuR expression in whole-cell (Total [20
mg]), nuclear (10 mg), or cytoplasmic (Cytopl. [40 mg]) lysates from
either WI-38 or IDH4 populations (young or senescent [Sen.], as de-
scribed in the legend to Fig. 1A). Western blot analysis of BAF57c and
b-actin expression served to assess the quality of the cell fractionation
procedure and to monitor differences in loading and transfer among
samples. Western blot signals were quantitated and represented (graph)
relative to the total protein present in whole-cell lysates from young
cells. Y, young; S, senescent. (B) Western blot analyses depicting time-
dependent changes in total HuR expression in dex-depleted (2Dex)
IDH4 cells or in WI-38 cells of the indicated number of population
doublings.
FIG. 4. HuR expression in ﬁbroblasts from skin biopsies from
young and elderly individuals. Western blot analysis of expression of
the proteins indicated was carried out using ﬁbroblasts from skin
biopsies obtained from individual donors who were either young (15 to
30 years old) or aged (80 to 94 years old). The ﬁbroblasts were cultured
in vitro for 3 to 4 pdl before Western blot analysis of whole-cell lysates.
The error bars represent standard errors of the mean.
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for c-fos). By contrast, similar fold excess of a nonspeciﬁc
transcript (cyclin E 39 UTR) failed to compete for binding
(Fig. 6B).
Ectopic intervention to either elevate or reduce HuR expres-
sion can alter the half-lives of target senescence-associated
mRNAs. Next, we sought to determine if the observed differ-
ences in HuR levels in young and senescent cells directly in-
FIG. 5. HuR binding to target mRNAs in young and senescent human ﬁbroblasts. Radiolabeled RNAs encoding the 39 UTRs of c-fos, cyclin
A, cyclin B1, and cyclin E are shown (top; underlined). Radiolabeled transcripts were incubated with proteins present in either nuclear (Nuc.)o r
cytoplasmic lysates of young (Y) or senescent (S) WI-38 or IDH4 cells (deﬁned in the legend to Fig. 3), forming associations with slower
electrophoretic mobilities (bottom). Complexes formed with lysates from IDH4 cells and radiolabeled transcripts were assayed for the ability to
be supershifted by either anti-HuR antibodies (a-HuR), or control anti-p27, anti-p38, or anti-p53 antibodies (a-p27, a-p38, and a-p53, respec-
tively), as shown. f, free probes; arrows, supershifted complexes.
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we chose to utilize IDH4 cells grown without dex for 3 to 4
days, which rendered their phenotype intermediate between
those of young (with dex) and senescent (without dex for 7
days) ﬁbroblasts and allowed us to monitor HuR-dependent
changes leading to the acquisition of younger or more “senes-
cencelike” traits. Cells that had been transiently transfected
with an empty vector (zeo) or with vectors expressing either
HuR (S) or an antisense transcript complementary to HuR
mRNA (AS) (see Materials and Methods) were grown without
dex for 3 to 4 days. Parallel transfections using an enhanced
green ﬂuorescent protein expression vector revealed that 75 to
90% of the cells were transfected under our experimental
conditions (not shown). WI-38 cells were not amenable to such
transfection-driven changes in HuR expression levels due to
their very low transfection rates. As shown in Fig. 7, by day 3
such transient overexpression of HuR(S) in senescent IDH4
cells led to an '4-fold increase in HuR levels, while HuR(AS)
expression led to an '3.5-fold decrease in HuR levels relative
to transfections using an empty vector. Levels of the constitu-
tively expressed nuclear protein BAF57c served as a control for
loading, while levels of the RNA-binding AUF1 protein family
were not signiﬁcantly altered. Accordingly, lysates prepared
from each transfection group formed complexes with tran-
scripts encoding the 39 UTRs of cyclin A, cyclin B1, and c-fos
that were in keeping with HuR levels: compared with control
cells (zeo), binding was higher in HuR-overexpressing cells and
lower in cells with reduced HuR expression (S and AS, respec-
tively) (Fig. 7B).
These interventions to either elevate or reduce HuR expres-
sion levels affected the steady-state levels and half-lives of
target mRNAs. As shown in Fig. 8, the expression levels, as
well as the half-lives, of mRNAs encoding cyclins A and B1
were longer in the HuR(S) transfection group and shorter in
the HuR(AS) transfection group than they were in control,
empty-vector-transfected group (as measured by day 3 without
dex). For cyclin A mRNA, half-lives were 2.7 h for the zeo
transfection group, 3.3 h for the HuR(S) group, and2hf o r
HuR(AS); for cyclin B1 mRNA, half-lives were 2.8 h for zeo
control, 3.8 h for HuR(S), and 2 h for HuR(AS). c-fos mRNA
signals were too low to measure accurately in actinomycin
D-based experiments. By contrast, HuR levels did not inﬂu-
FIG. 6. Time course of complex formation in cells undergoing senescence, showing speciﬁcity of binding to target radiolabeled transcripts. (A)
Cytoplasmic lysates from IDH4 cells cultured without dex (2Dex) for the indicated times were incubated with radiolabeled cyclin A, cyclin B1,
or c-fos transcripts. (B) IDH4 cytoplasmic lysates were incubated with 53,1 0 3,o r2 0 3 excess unlabeled competitor transcripts. Lanes Sp,
competition using a speciﬁc transcript (unlabeled cyclin [cyc] A RNA competing for binding of radiolabeled cyclin A RNA, unlabeled cyclin B1
RNA competing for binding of radiolabeled cyclin B1 RNA, and likewise for c-fos RNA); lanes Non-Sp, competition using unlabeled cyclin E RNA
as a nonspeciﬁc transcript in binding assays with radiolabeled cyclin A RNA, cyclin B1 RNA, and c-fos RNA.
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trol mRNAs, those encoding gadd153 and b-actin (Fig. 8).
Taken together, these observations suggest that high HuR
levels, such as are found in young cells, contribute to maintain-
ing high expression of cyclin A, cyclin B1, and c-fos, all three
important proliferation-associated genes, while decreased HuR
expression in senescent cells contributes to lowering their ex-
pression.
Ectopic intervention to either elevate or reduce HuR expres-
sion in IDH4 cells can alter their senescence phenotype. Given
HuR’s ability to regulate the mRNA levels of genes whose
expression is reduced with senescence, we postulated that HuR
expression levels could directly inﬂuence the implementation
(onset and/or maintenance) of the senescence phenotype.
Consistent with this view, overexpression of HuR in IDH4 cells
grown without dex for 3 to 4 days revealed a younger pheno-
type than did vector-transfected (zeo) cells, as the cells exhib-
ited higher cdk activity, proliferation, and
3H-thymidine in-
corporation (Fig. 9) while they displayed a lower proportion
of SA-b-gal-positive cells (Fig. 10). By contrast, populations
where HuR expression was suppressed displayed more pro-
nounced characteristics of senescence, with lower basal cdk ac-
tivity, fewer cells, less
3H-thymidine incorporation, and a dra-
matically higher number of enlarged, SA-b-gal-positive cells
(Fig. 9 and 10).
DISCUSSION
The data presented here provide novel insight into the reg-
ulation of gene expression during replicative senescence. Using
FIG. 7. Inﬂuence of HuR levels on the formation of protein com-
plexes with the 39 UTRs of senescence-associated genes. (A) Western
blot analysis of expression of the indicated genes was carried out using
IDH4 cells transiently transfected with either empty vector (zeo),
HuR-expressing (S), or antisense-HuR-expressing (AS) plasmid
pZeoSV2(2) and then cultured in the absence of dex for 3 days. (B)
Binding of radiolabeled RNAs corresponding to the 39 UTRs of cyclin
(cyc) A, cyclin B1, and c-fos and proteins present in the cytoplasmic
lysates (10 mg) of IDH4 cells cultured as described for panel A. Fold
differences in intensity of shifted complexes, relative to those in zeo
populations, are shown below the lanes.
FIG. 8. Inﬂuence of HuR levels on the steady-state levels and stabilities of senescence-associated genes. Three days after transfection and
removal of dex (as described in the legend to Fig. 7), expression of cyclin A, cyclin B1, and c-fos was assessed in IDH4 cells. (A) Representative
Northern blots depicting the steady-state levels of cyclin (cyc) A, cyclin B1, c-fos, gadd153, and b-actin mRNAs, as well as 18S rRNA, and
quantitations from 10 independent experiments (bar graph, showing means 1 standard errors of the means [SEM]). (B) Cyclin A, cyclin B1, b-actin, and
gadd153 mRNA stabilities, assessed as explained in the legend to Fig. 2B; the values represent the means 6 SEM of seven independent experiments.
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expression of the RNA-binding protein HuR, as well as bind-
ing of HuR to target mRNAs encoding cyclin A, cyclin B1, and
c-fos, decreases with replicative senescence (Fig. 3 and 5).
Both the half-lives and expression levels of these mRNAs are
elevated in young cells, where HuR is abundant, but are low in
senescent cells, where HuR expression is diminished. We fur-
ther show that transfected IDH4 cells overexpressing HuR
displayed elevated stability of target mRNAs, while those ex-
pressing lower HuR levels showed reduced target mRNA half-
lives. Importantly, such manipulations of HuR expression af-
fected the senescence phenotype of IDH4 cells. As shown in
Fig. 9 and 10, cells overexpressing HuR displayed features of
young cells (lower SA-b-gal activity and higher cdk activity and
3H-thymidine incorporation) compared with empty-vector-
transfected cells, while cells expressing reduced HuR levels
displayed an enhanced senescent phenotype (higher SA-b-gal
activity and diminished cdk activity, proliferation, and
3H-thy-
midine incorporation).
To date, the expression of replicative-senescence-associated
genes has been studied by comparing collections of genes ex-
pressed in various young and senescent cell systems, but the
underlying mechanisms serving to coordinately regulate their
expression (for example, transcriptional regulators) have re-
mained elusive. Based on our results reported here, we pro-
pose that changes in mRNA stability may constitute an effec-
tive means of globally regulating age-related gene expression.
Coordinate, HuR-dependent changes in the expression of cy-
clin A, cyclin B1, and c-fos (whose mRNAs are known targets
of HuR [25, 35]) may have a direct impact on the senescence
phenotype, since these genes are critical regulators of cellular
proliferation and cell cycle progression. However, it is likely
that additional HuR target genes collectively participate in the
implementation of the senescence phenotype, its maintenance,
or both. In this regard, HuR was found to bind transcripts
corresponding to other senescence-related genes, such as those
for MnSOD and DP-1 (not shown).
Based on earlier observations that (i) elevated p21 is a hall-
mark of entry into senescence, (ii) HuR stabilized the p21
mRNA after exposure to UV irradiation (34), and (iii) to our
knowledge, no senescence-associated activators of p21 tran-
scription have been reported, we initially set out to examine if
HuR enhanced p21 mRNA in our study system. Surprisingly,
HuR does not appear to be responsible for upregulating p21
FIG. 9. Inﬂuence of HuR levels on the senescent phenotype. IDH4
cells transfected as described in the legend to Fig. 7 (zeo, S, and AS)
were cultured without dex for either 3 or 6 days and then subjected to
assessment and quantitation of cdk2- and cdc2-associated kinase ac-
tivity using histone H1 as a substrate (A),
3H-thymidine (Thym.) in-
corporation (B), or total cell numbers (C). The graphs represent the
means 6 standard errors of the means of four independent experi-
ments.
FIG. 10. Inﬂuence of HuR levels on SA-b-gal activity. IDH4 cells
transfected as described in the legend to Fig. 7 (zeo, S, and AS) were
cultured without dex for 4 days and then stained to assess SA-b-gal
activity. Top, representative ﬁelds; bottom, quantitation of SA-b-gal-
positive IDH4 cells. The graph represents the means 1 standard errors
of the means of four independent experiments.
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cellular stress response) based on our data presented here
(Fig. 2). Systematic studies aimed at examining HuR-regulated
changes in gene expression are under way in our laboratory
using DNA arrays. We anticipate ﬁnding additional senes-
cence-associated genes using this strategy.
According to the model emerging from the present study,
high HuR expression in young cells has a direct impact on the
cellular phenotype, characterized by a highly proliferative state
(in which cyclin A, cyclin B1, and c-fos are known to be major
participants). Likewise, low HuR expression in senescent cells
contributes to maintaining reduced levels of such proliferative
genes. A corollary of our hypothesis is that cells expressing
high levels of HuR are likely to have high proliferation rates.
In this regard, it is of interest to note that HuR was more
highly expressed in skin ﬁbroblasts from young individual do-
nors (Fig. 4) and that high HuR expression levels were found
in neoplastic tissues and were correlated with rapid growth,
both in vivo and in vitro (1). Likewise, HuR was found to be
highly expressed in virtually all tumors examined (H. Fur-
neaux, personal communication). In conclusion, while HuR
expression could be a consequence of replicative senescence,
the ability of HuR manipulations to alter the senescent phe-
notype suggests a direct participation of HuR in the process of
in vitro senescence.
Although the link between in vitro cellular senescence and
human aging remains controversial, a diminution in prolifera-
tive capacity is also a hallmark of in vivo aging. Therefore,
knowledge of the mechanisms serving to regulate gene expres-
sion during in vitro senescence is likely to aid our understand-
ing of in vivo aging as well as contribute to our comprehension
of age-related diseases, such as cancer and hyperplasia, where
control of proliferation is lost. As in cancer, where clearly more
genes are abnormally expressed than are mutated (29), it is
plausible that conditions associated with aging also arise as a
consequence of deregulated gene expression rather than mu-
tations. Thus, while single-gene approaches to intervene in
such conditions have been unfruitful, it is likely that strategies
aimed at modulating global patterns of gene expression will
prove more successful.
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